<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345580</id>
  <title nil="true"/>
  <common-name>N-[(3s,5s,10s,13s,17s)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-(4-methylpiperazin-1-yl)acetamide</common-name>
  <description>N-[(3s,5s,10s,13s,17s)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-(4-methylpiperazin-1-yl)acetamide is a compound with the formula C26H45N3O2. It has an average molecular weight of 431.70 g/mol.</description>
  <cas>114967-70-3</cas>
  <pubchem-id>3087513</pubchem-id>
  <chemical-formula>C26H45N3O2</chemical-formula>
  <weight>431.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:29:01Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:29:01Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC12CCC(CC1CCC3C2CCC4(C3CCC4NC(=O)CN5CCN(CC5)C)C)O</moldb-smiles>
  <moldb-formula>C26H45N3O2</moldb-formula>
  <moldb-inchi>InChI=1S/C26H45N3O2/c1-25-10-8-19(30)16-18(25)4-5-20-21-6-7-23(26(21,2)11-9-22(20)25)27-24(31)17-29-14-12-28(3)13-15-29/h18-23,30H,4-17H2,1-3H3,(H,27,31)/t18-,19-,20?,21?,22?,23-,25-,26-/m0/s1</moldb-inchi>
  <moldb-inchikey>QFBNAGXBPHDTHX-CUTQXZKCSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">431.3511777</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341473</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[(3s,5s,10s,13s,17s)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-(4-methylpiperazin-1-yl)acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Steroids and steroid derivatives</klass>
  <subklass>Androstane steroids</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0295936</sync-id>
  <structure-inchikey>QFBNAGXBPHDTHX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>200000040000000208000004000000000800000000000000100000000000000000400000000000000000000000000100000000100000000400000000000000120c0000000200000020000000200000020000000000000000000000000000001000000010000000000000000000008000000020100000000000000008000100000002048000000010000000000004080200000000000000000080000400020000800008004000008000000000000000000800000004000048000000000080000000000000000000000000000000000000000000000000000000000000000010000000000000000000000000000000480000001000000080000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAIwAAAIABBgBgAAAAAQMGACAAAAAE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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:35Z</structure-indexed-at>
</compound>
